H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?

European Journal of Haematology

Volumn 78, Issue 1, 2007, Pages 66-71

  De Diego, Carles ^a   Opazo, Sonsoles ^a   Murga, Maria J ^a   Martínez Castro, Pedro ^a  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

Author keywords

H63D homozygotes; HFE gene; Hyperferritinaemia; Iron overload

Indexed keywords

FERRITIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA MODIFICATION; FEMALE; FERRITIN BLOOD LEVEL; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; HYPERFERRITINEMIA; IRON OVERLOAD; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; FEMALE; FERRITINS; GENOTYPE; HEMOCHROMATOSIS; HOMOZYGOTE; HUMANS; IRON METABOLISM DISORDERS; IRON OVERLOAD; MALE; MIDDLE AGED;

EID: 33845902249     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2006.00775.x     Document Type: Article

References (29)

1. Powell LW, Jazwinska E, Halliday J. Changing concepts of haemochromatosis. Adv Exp Med Biol 1994;356:285-91.
2. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like is mutated in patients with hereditary haemochromatosis. Nature Genet 1996;13:399-408.
3. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RC. The hemochromatosis gene product complexes with the transferrin receptor and lowers the affinity for ligand binding. Proc Natl Acad Sci USA 1998;95: 1472-7.
4. Mura C, Raguénes O, Férec C. HFE mutation analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 1999;93:2502-5.
5. Le Gac G, Mura C, Ferec C. Complete scanning of the hereditary hemochromatosis gene (HFE) by use of denaturing HPLC. Clin Chem 2001;47:1633-40.
6. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ. Geography of HFE C282Y and H63D mutations. Genet Testing 2000;4:183-98.
7. Lucotte G, Dieterlen F. A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation? Blood Cells Mol Dis 2003;31:262-7.
8. Milman N, Koefoed P, Pedersen P, Nielsen FC, Eiberg H. Frequency of the HFE C282Y and H63D mutations in Danish patients with clinical haemochromatosis initially diagnosed by phenotypic methods. Eur J Haematol 2003;71:403-7.
9. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718-24.
10. Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynyk JK. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 2002;122:646-51.
11. Beutler E. (H63D) mutation in hemochromatosis. Am J Hum Genet 187G 1997; 762-4.
12. Aguilar-Martinez P, Bismuth M, Picot MC, Thelcide C, Pageaux GP, Blanc F, Blanc P, Schved JF, Larrey D. Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut 2001;48:836-42.
13. Njajou OT, Houwing-Duistermaat JJ, Osborne RH, Vaessen N, Vergeer J, Heeringa J, Pols HA, Hofman A, van Duijn CM. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism. Eur J Hum Genet 2003;11:225-31.
14. de Juan D, Reta A, Castiella A, Pozueta J, Prada A, Cuadrado E. HFE gene mutations analysis in Basque hereditary haemochromatosis patients and controls. Eur J Hum Genet 2001;9:961-4.
15. Baiget M, Barcelo MJ, Gimferrer E. Frequency of the HFE C282Y and H63D mutations in distinct ethnic groups living in Spain. J Med Genet 1998;35:701.
16. Guix P, Picornell A, Parera M, Galmes A, Obrador A, Ramon MM, Castro JA. Distribution of HFE C282Y and H63D mutations in the Balearic Islands (NE Spain). Clin Genet 2002;61:43-8.
17. de Diego C, Murga MJ, Martínez-Castro P. Frequency of HFE H63D, S65C, and C282Y mutations in patients with iron overload and controls from Toledo, Spain. Genet Test 2004;8:263-7.
18. Remacha AF, Sarda MP, Barcelo MJ, Bach V, Altes A, Baiget M, Guarner C, Blesa I. Genotype-phenotype correlation in a Spanish population homozygous for the H63D mutation of the HFE gene. Ann Hematol 2006;36:288-91.
19. Tomatsu S, Orii KO, Fleming RE, Holden CC, Waheed A, Britton RS, Gutierrez MA, Velez-Castrillon S, Bacon BR, Sly WS. Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis. Proc Natl Acad Sci USA 2003;100:15788-93.
20. Merryweather-Clarke AT, Cadet E, Bomford A, et al. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Molec Genet 2003;12:2241-7.
21. Rhodes DA, Raha-Chowdhury R, Cox TM, Trowsdale J. Homozygosity for the predominant Cys282Tyr mutation and absence of disease expression in hereditary haemochromatosis. J Med Genet 1997;34:761-4.
22. Lyon E, Frank EL. Hereditary hemochromatosis since discovery of the HFE gene. Clin Chem 2001;47:1147-56.
23. Phatak PD, Ryan DH, Cappuccio J, Oakes D, Braggins C, Provenzano K, Eberly S, Sham RL. Prevalence and penetrance of HFE mutations in 4854 unselected primary care patients. Blood Cells Mol Dis 2002;29:41-7.
24. Samarasena J, Winsor W, Lush R, Duggan P, Xie Y, Borgaonkar M. Individuals homozygous for the H63D mutation have significantly elevated iron indexes. Dig Dis Sci 2006;51:803-7.
25. Sebastiani G, Wallace DF, Davies SE, Kulhalli V, Walker AP, Dooley JS. Fatty liver in H63D homozygotes with hyperferritinemia. World J Gastroenterol 2006;12:1788-92.
26. Matas M, Guix P, Castro JA, Parera M, Ramon MM, Obrador A, Picornell A. Prevalence of HFE C282Y and H63D in Jewish populations and clinical implications of H63D homozygosity. Clin Genet 2006;69:155-62.
27. Le Gac G, Scotet V, Ka C, Gourlaouen I, Bryckaert L, Jacolot S, Mura C, Ferec C. The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. Hum Mol Genet 2004;13:1913-8.
28. Biasiotto G, Roetto A, Daraio F, Polotti A, Gerardi GM, Girelli D, Cremonesi L, Arosio P, Camaschella C. Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele. Blood Cells Mol Dis 2004;33:338-43.
29. Altes A, Remacha AF, Sureda A, Martino R, Briones J, Brunet S, Baiget M, Sierra J. Patients with biochemical iron overload: causes and characteristics of a cohort of 150 cases. Ann Hematol 2003;82:127-30.